Replies to post #4075 on GTC Biotherapeutics (fka GTCB)

[cesrph09]

There sometimes just isn't a conspiracy theory. Quite simple: the market deems GTCB's value at around 1.20ish. Until GTCB offers some monumental news, I don't expect much change for the + or -.

[croumagnon]

"If there is no new angle—and there wasn’t one today—please try to resist the urge to make repetitive postings."

There was a new angle today (yesterday) and it was mainly that even the EU launch is not pulling GTCB past $1.2. As for repetitive posts, most of the posts lately (scientific or not) have been repetitive since other than the news of yesterday nothing new of importance has happened...

We are all here for two main purposes: to learn and to to try to make money. This is not a scientific journal so trying to focus all the conversation on the sciences is a bit foolish IMO. It is very important to our understanding of the facts and to our belief in the future of the company. However, the pps is also an important measure of the success of the company and our ability to make money investing in GTCB. The fact that the stock is pinned at $1.2, for whatever reason, is an enigma that, whether you like or not, is on the minds of many investors and traders here. Making suggetions as to why this is so is very helpful to generate a conversation about various thoughts on the matter...

As for Genzyme, you seem to have an aversion to stating that they may have anything to do with a possible takeover eventually or that they may be manipulating or unloading their stock. I do not understand why you are so adament in your position on this matter when GTCB is an offshoot of Genzyme, Genzyme is the largest shareholder, and genzyme has been known to make opportunistic acquisitions in the past. Your stating that Genzyme has plenty of other issues on the table to spend any time focusing on GTCB is almost laughable. Genzyme is a big corporation and I am sure they can manage to run their daily affairs and still be able to consider the GTCB possibilities...

Do not get me wrong Dew. I appreciate your posts on GTCB and I consider them very valuable. I also think you do an excellent job moderating this board as well as the biotech values board. However, I think you are being a bit too dogmatic in dismissing the manipulative factors that may be pinning GTCB's stock to $1.2...